Table 4 Multivariable analysis of prognostic factors of all 82 NPC patients with residual cervical lymphadenopathy

0.827 (0.408–1.675)

0.598

1.604 (0.625–4.113)

0.326

0.440 (0.148–1.308)

0.140

0.728 (0.331–1.600)

0.429

0.619 (0.224–1.715)

0.357

1.328 (0.507–3.479)

0.564

0.699 (0.336–1.454)

0.338

0.503 (0.164–1.542)

0.230

0.467 (0.148–1.472)

0.194

0.533 (0.237–1.197)

0.127

0.531 (0.189–1.492)

0.230

0.585 (0.211–1.619)

0.302

2.739 (1.173–6.397)

0.020

4.114 (1.140–14.847)

0.031

10.722 (2.408–47.740)

0.002

1.536 (0.611–3.861)

0.361

1.433 (0.437–4.702)

0.553

2.606 (0.803–8.465)

0.111

2.735 (0.761–9.837)

0.123

2.530 (0.577–11.090)

0.218

9.408 (1.465–60.435)

0.018

1.475 (0.367–5.927)

0.583

2.379 (0.359–15.749)

0.369

2.085 (0.416–10.446)

0.372

0.516 (0.214–1.246)

0.142

1.309 (0.421–4.071)

0.642

0.384 (0.095–1.549)

0.179

0.637 (0.266–1.530)

0.313

0.408 (0.120–1.392)

0.152

0.740 (0.244–2.242)

0.594

1.360 (0.658–2.811)

0.407

0.777 (0.276–2.184)

0.632

1.639 (0.548–4.901)

0.377

1.912 (0.843–4..338)

0.121

1.000 (0.357–2.798)

0.999

3.576 (1.010–12.658)

0.048

1.546 (0.758–3.151)

0.231

5.535 (1.677–18.268)

0.005

1.898 (0.655–5.499)

0.238

1.571 (0.733–3.365)

0.245

2.622 (0.944–7.286)

0.064

2.804 (1.018–7.727)

0.046

5.209 (1.185–22.900)

0.029

–

9.265 (1.035–82.935)

0.047

10.175 (1.273–81.320)

0.029

4.158 (0.457–37.820)

0.206

–

1.282 (0.780–2.108)

0.327

1.702 (0.711–4.070)

0.232

2.619 (0.929–7.383)

0.069

1.141 (0.672–1.938)

0.626

0.865 (0.476–1.573)

0.635

2.398 (0.971–5.922)

0.058